A detailed history of Sherbrooke Park Advisers LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 48,270 shares of HCAT stock, worth $369,748. This represents 0.09% of its overall portfolio holdings.

Number of Shares
48,270
Previous 20,132 139.77%
Holding current value
$369,748
Previous $129 Million 205.43%
% of portfolio
0.09%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.48 - $8.83 $154,196 - $248,458
28,138 Added 139.77%
48,270 $393 Million
Q2 2024

Aug 14, 2024

BUY
$5.53 - $7.28 $30,448 - $40,083
5,506 Added 37.65%
20,132 $129 Million
Q1 2024

May 15, 2024

BUY
$7.44 - $11.21 $27,029 - $40,725
3,633 Added 33.05%
14,626 $110 Million
Q4 2023

Feb 14, 2024

BUY
$6.71 - $10.16 $73,763 - $111,688
10,993 New
10,993 $102 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $419M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.